Kaken Pharmaceutical Co Ltd
TSE:4521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
JP |
|
T
|
Tpcs PCL
SET:TPCS
|
TH |
|
Silicom Ltd
NASDAQ:SILC
|
IL |
|
E
|
Ege Profil Ticaret ve Sanayi AS
IST:EGPRO.E
|
TR |
|
Tanseisha Co Ltd
TSE:9743
|
JP |
|
Polyplex Corp Ltd
NSE:POLYPLEX
|
IN |
|
Almirall SA
MAD:ALM
|
ES |
|
P
|
Panasonic Holdings Corp
DUS:MAT1
|
JP |
|
B
|
Brooker Group PCL
SET:BROOK
|
TH |
|
Intense Technologies Ltd
NSE:INTENTECH
|
IN |
|
R
|
Ryerson Holding Corp
F:7RY
|
US |
|
A
|
Altri SGPS SA
ELI:ALTR
|
PT |
|
Alianza Minerals Ltd
XTSX:ANZ
|
CA |
|
GD Entertainment & Technology Inc
OTC:GDET
|
US |
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
US |
|
B
|
Borussia Dortmund GmbH & Co KGaA
XHAM:BVB
|
DE |
|
Huang Hsiang Construction Corp
TWSE:2545
|
TW |
|
Leading Edge Materials Corp
XTSX:LEM
|
CA |
Bankruptcy Probability
Kaken Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kaken Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
147.9B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
662.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
371.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
212.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
264.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kaken Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kaken Pharmaceutical Co Ltd has total debt of 3.9B JPY. This includes both short-term (3.9B JPY) and long-term (0 JPY) debt.
You can find a full breakdown on its Balance Sheet.
